Altered Enhancer and Promoter Usage Leads to Differential Gene Expression in the Normal and Failed Human Heart

Abstract

This data set defines the dynamic genomic regulatory landscape underlying heart failure and serves as an important resource for understanding genetic contributions to cardiac dysfunction. Additionally, regulatory changes contributing to heart failure are attractive therapeutic targets for controlling ventricular remodeling and clinical progression.